| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, and liver cancers. Notably, Adva-27a also demonstrates efficacy against multidrug-resistant cancer cells, …
Over the last 12 months, insiders at Sunshine Biopharma, Inc. have bought $0 and sold $0 worth of Sunshine Biopharma, Inc. stock.
On average, over the past 5 years, insiders at Sunshine Biopharma, Inc. have bought $21,802 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100,000 shares for transaction amount of $10,000 was made by Slilaty Steve N. (Chief Executive Officer) on 2024‑03‑04.
| 2024-03-04 | Slilaty Steve N. | Chief Executive Officer | 100,000 – | $0.10 | $10,000 | -96.58% | ||
| 2024-02-08 | Slilaty Steve N. | Chief Executive Officer | 20,000 – | $0.10 | $2,000 | -99.27% | ||
| 2022-11-30 | Sebaaly Camille | CFO/Secretary | 30,000 0.1533% | $0.76 | $22,905 | -18.54% | ||
| 2022-06-03 | Sebaaly Camille | CFO/Secretary | 25,000 0.1577% | $1.22 | $30,500 | -11.89% | ||
| 2016-04-12 | Slilaty Steve N. | Chief Executive Officer | 253,082 – | $0.20 | $50,009 | |||
| 2015-05-27 | Slilaty Steve N. | Chief Executive Officer | 500,000 – | $0.10 | $50,000 | |||
| 2012-09-04 | Sale | Slilaty Steve N. | Chief Executive Officer | 2.59M – | $0.05 | $129,575 |
| Increased Positions | 6 | +31.58% | 52,013 | +22.97% |
| Decreased Positions | 7 | -36.84% | 163,413 | -72.18% |
| New Positions | 4 | New | 39,546 | New |
| Sold Out Positions | 5 | Sold Out | 139,253 | Sold Out |
| Total Postitions | 18 | -5.26% | 114,999 | -49.21% |
| Citadel Advisors Llc | $100.00 | 1.56% | 78,087 | +14,656 | +23.11% | 2025-09-30 |
| Renaissance Technologies Llc | $71.00 | 1.11% | 55,700 | +1,607 | +2.97% | 2025-09-30 |
| Drw Securities, Llc | $58.00 | 0.9% | 44,977 | +44,977 | New | 2025-09-30 |
| Two Sigma Investments, Lp | $27.00 | 0.43% | 21,399 | +21,399 | New | 2025-09-30 |
| Two Sigma Securities, Llc | $22.00 | 0.34% | 17,176 | +17,176 | New | 2025-09-30 |
| Sbi Securities Co., Ltd. | $6.00 | 0.1% | 4,850 | -1,844 | -27.55% | 2025-09-30 |
| Morgan Stanley | $5.00 | 0.08% | 3,834 | 0 | 0% | 2025-09-30 |
| Ubs Group Ag | $0 | <0.01% | 206 | 0 | 0% | 2025-09-30 |
| Osaic Holdings, Inc. | $0 | <0.01% | 152 | 0 | 0% | 2025-09-30 |
| National Bank Of Canada /Fi/ | $0 | 0% | 10 | 0 | 0% | 2025-09-30 |